Covid-19: Almost 10,000 people tested negative before flying Just one was positive after landing, a study shows stuff.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stuff.co.nz Daily Mail and Mail on Sunday newspapers.
Last Updated:
Pfizer, Moderna Vaccines May Greatly Reduce Risk Of Asymptomatic Covid Infection: Study
Asymptomatic coronavirus patients showed an 80 percent lower adjusted risk of testing positive for the disease after two doses of a mRNA COVID-19 vaccine
While the world is in pursuit to win the battle through their vaccination drive against the COVID-19 pandemic, the effect of vaccines on asymptomatic coronavirus patients still remains unknown. Now, a study has revealed that the Pfizer-BioNTech and Moderna messenger RNA (mRNA) can greatly reduce the risk of asymptomatic coronavirus Infection.
The study said that the asymptomatic coronavirus patients (who do not show any signs or symptoms of the disease on contracting it for the entire duration of the incubation period) are far less likely to test positive and unknowingly spread COVID-19 ten days after receiving the second dose of a messenger RNA vaccine, compared to those who have not been vaccinated.
Mayo study: mRNA vaccines shield against COVID-19 infection
Finding is first discovery within the US that the shots prevent not only symptomatic illness, but getting the virus in the first place 5:08 pm, Mar. 11, 2021 ×
Vials of the Pfizer vaccine sit in an Essentia Health storage freezer. (Submitted Photo)
ROCHESTER, Minn. New research shows if you get vaccinated against COVID-19, chances are good you can t get infected with the virus or spread it to others.
That s the takeaway of a large Mayo Clinic study published Thursday, March 11 in the journal Clinical Infectious Diseases.
The review of over 48,000 consecutive electronic tests within Mayo found the mRNA vaccines manufactured by Pfizer-BioNTech and Moderna are not only effective at preventing symptomatic illness, they greatly reduce the risk of contracting it in the first place. The vast majority of vaccine recipients studied (95%) received the shots made by Pfizer-BioNTech.